Total Payments
$724.34
2024 Payments
$150.83
Companies
5
Transactions
33
Medicare Patients
439
Medicare Billing
$127,044
Payment Breakdown by Category
Food & Beverage$724.34 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $724.34 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $644.49 | 29 | $0 (2024) |
| Theravance Biopharma, Inc. | $23.16 | 1 | $0 (2018) |
| Paratek Pharmaceuticals, Inc. | $22.56 | 1 | $0 (2024) |
| Allergan Inc. | $20.18 | 1 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $13.95 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150.83 | 5 | Merck Sharp & Dohme LLC ($128.27) |
| 2023 | $82.68 | 3 | Merck Sharp & Dohme LLC ($82.68) |
| 2022 | $115.17 | 5 | Merck Sharp & Dohme LLC ($115.17) |
| 2021 | $152.93 | 8 | Merck Sharp & Dohme Corporation ($152.93) |
| 2020 | $19.41 | 1 | Merck Sharp & Dohme Corporation ($19.41) |
| 2019 | $72.14 | 4 | Merck Sharp & Dohme Corporation ($72.14) |
| 2018 | $77.36 | 4 | Merck Sharp & Dohme Corporation ($54.20) |
| 2017 | $53.82 | 3 | Allergan Inc. ($20.18) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/31/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/29/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/08/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: ANTIBIOTIC | ||||||
| 11/01/2023 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $31.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/13/2023 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/02/2023 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/14/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/07/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/20/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/30/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/19/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/08/2021 | Merck Sharp & Dohme Corporation | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/13/2021 | Merck Sharp & Dohme Corporation | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/29/2021 | Merck Sharp & Dohme Corporation | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/14/2021 | Merck Sharp & Dohme Corporation | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/07/2021 | Merck Sharp & Dohme Corporation | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/09/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), RECARBRIO, ZINPLAVA | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/28/2021 | Merck Sharp & Dohme Corporation | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/31/2021 | Merck Sharp & Dohme Corporation | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/19/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/20/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/25/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/20/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 108 | 160 | $236,073 | $23,830 |
| 2022 | 2 | 99 | 172 | $259,154 | $27,244 |
| 2021 | 2 | 102 | 211 | $299,739 | $35,973 |
| 2020 | 3 | 130 | 249 | $282,953 | $39,998 |
Total Patients
439
Total Services
792
Medicare Billing
$127,044
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 64 | 112 | $212,989 | $19,125 | 9.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 48 | $23,084 | $4,705 | 20.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 65 | 133 | $241,291 | $23,921 | 9.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 39 | $17,863 | $3,323 | 18.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 77 | 185 | $286,976 | $33,735 | 11.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 25 | 26 | $12,763 | $2,238 | 17.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 78 | 186 | $248,034 | $34,364 | 13.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 34 | 44 | $22,289 | $3,850 | 17.3% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 18 | 19 | $12,630 | $1,784 | 14.1% |
About Dr. Ranju Soni, M.D
Dr. Ranju Soni, M.D is a Internal Medicine healthcare provider based in Poway, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417991282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ranju Soni, M.D has received a total of $724.34 in payments from pharmaceutical and medical device companies, with $150.83 received in 2024. These payments were reported across 33 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($724.34).
As a Medicare-enrolled provider, Soni has provided services to 439 Medicare beneficiaries, totaling 792 services with total Medicare billing of $127,044. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Pulmonary Disease
- Location Poway, CA
- Active Since 06/15/2006
- Last Updated 10/02/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417991282
Products in Payments
- ZERBAXA (Drug) $379.79
- DIFICID (Drug) $134.92
- RECARBRIO (Drug) $129.78
- VIBATIV (Drug) $23.16
- NUZYRA (Drug) $22.56
- DALVANCE (Drug) $20.18
- BROVANA (Drug) $13.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Poway
Dr. Stuart Klein, Md, MD
Internal Medicine — Payments: $14,761
Internal Medicine $14,761
Dr. Akber Safi, Md, MD
Internal Medicine — Payments: $12,421
Internal Medicine $12,421
Kathy Clewell, M.d, M.D
Internal Medicine — Payments: $9,441
Internal Medicine $9,441
Sandeep Soni, M.d, M.D
Internal Medicine — Payments: $7,743
Internal Medicine $7,743
Elizabeth Salada, M.d, M.D
Internal Medicine — Payments: $5,856
Internal Medicine $5,856
David Carty, Md, MD
Internal Medicine — Payments: $4,675
Internal Medicine $4,675